{"id":1355167,"title":"DSEN Abstract: Angiotensin receptor blocker use in the US, UK, Canada, and Denmark after the nitrosamine recalls of 2018 - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-10","captureTimestamp":"2026-04-10T06:41:38.430000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53926.html","snippet":"DSEN Abstract Angiotensin receptor blocker use in the US, UK, Canada, and Denmark after the nitrosamine recalls of 2018 A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) In Canada, an immediate steep decline in valsartan use was observed…","rawSnapshotUrl":"/api/snapshots/raw/1355167","browseUrl":"https://replay.healtharchive.ca/job-8/20260410064138/https://cihr-irsc.gc.ca/e/53926.html#ha_snapshot=1355167","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}